Patent ID: 9446013
Filing Date: 2016-09-20
CPC Classification: A23L,A61K,A61P

Claim Text:
1. A method to reduce circulating oxLDL-beta-2-glycoprotein 1 complex in human sera comprising: administering to a person an effective amount of a dietary oil composition comprising mixture of 15-55 wt. % saturated fatty acids, 40-80 wt. % mono-unsaturated fatty acids, and 5-45 wt. % polyunsaturated fatty acids wherein the polyunsaturated fatty acids (PUFAs) Docsa Hexenoic acid (DHA), Eicosa Pentenoic Acid (EPA) and Docosa Pentenoic Acid (DPA) in a concentration ratio of about 35% DHA, about 35% EPA, and about 30% DPA.